Gemtesa 75 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQ1K9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,040
Award facts
- Contract value 100% obligated
- $22,039.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,039.85 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on September 3, 2025, with completion scheduled for September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and critical federal medical procurement vendor.
This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to military healthcare programs and other federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The current award for Gemtesa, a urological medication, exemplifies the company's role in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FQ1K9?
SPE2DB25FQ1K9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FQ1K9 worth?
The government has obligated $22,040 on SPE2DB25FQ1K9.
Is contract SPE2DB25FQ1K9 an order under another contract?
Yes. SPE2DB25FQ1K9 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ1K9 competed?
The extent of competition for SPE2DB25FQ1K9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award